Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …

Most of the contraindications to the administration of intravenous (IV) recombinant tissue
plasminogen activator (rtPA) originated as exclusion criteria in major stroke trials. These …

Importance More than half of patients with acute ischemic stroke have minor neurologic
deficits (National Institutes of Health Stroke Scale [NIHSS] score of 0-5) at presentation …

The original version of this consensus statement on mechanical thrombectomy was
approved at the European Stroke Organisation (ESO)-Karolinska Stroke Update conference …

卒中是致残和致死的主要疾病之一, 急性缺血性卒中约占全部卒中的80%.
急性缺血性卒中治疗的关键在于尽早开通阻塞血管, 挽救缺血半暗带. 目前被证实有效的急性缺 …

Background and Purpose—Acute ischemic stroke due to large vessel occlusion (LVO)—
vertebral, basilar, carotid terminus, middle and anterior cerebral arteries—likely portends a …

Background and Purpose—The term “minor stroke” is often used; however a consensus
definition is lacking. We explored the relationship of 6 “minor stroke” definitions and outcome …

Background Accurate assessment of the prevalence of large vessel occlusion (LVO) in
patients presenting with acute ischemic stroke (AIS) is critical for optimal resource allocation …

Background and Purpose—To describe the safety and effectiveness of a self-expanding and
fully retrievable stent (Solitaire AB; ev3 Inc, Plymouth, MN) in revascularization of patients …

The purpose of this study was to systematically review and summarize prehospital and in-
hospital stroke evaluation and treatment delay times. We identified 123 unique peer …